University Hospital of Patras

Rio 26500

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Non-small Cell Lung Cancer

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed